Skip to main contentAI and Advanced
/
AKSHARCHEM · BSEBSE SENSEX74,336.45+0.45%BSE |
NIFTY 5023,217.6+0.43%NSE |
NIFTY BANK56,292.45+0.89%NSE |
NIFTY IT29,087.65-1.58%NSE |
NIFTY AUTO26,893.65+0.51%NSE |
NIFTY FMCG45,559+1.63%NSE |
NIFTY PHARMA26,146.2-0.16%NSE |
NIFTY 50022,532+0.24%NSE |
AK
BSE · Equity shares · Chemical Manufacturing147.85 · -3.56%
AksharChem India Ltd AKSHARCHEM
NSE:INR 234.15
BSE:INR 382
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections8 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for AKSHARCHEM
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 234.15
Day rangeINR 230.11 — INR 235
52-week rangeINR 0 — INR 471.65
Volume78
Market cap190.39
P/ENot available
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)372.43
Net Income (INR Cr)-0.44
EPS-1.93
Research path: Interpret AksharChem India Ltd's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
AKSHARCHEMAksharChem India Ltd1d · INR · BSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 451.61 | 415.3 | 380.5 |
| Other Liabilities Total | 0.84 | 0.61 | 0.65 |
| Accrued Expenses | 0.67 | 3.31 | 3.17 |
| Long Term Debt | 17.88 | 13.32 | 17.47 |
| Common Stock Total | 8.03 | 8.03 | 8.03 |
| Other Current Assets Total | 14.28 | 1.65 | 2.44 |
| Total Assets | 451.61 | 415.3 | 380.5 |
| Current Portof LT Debt/Capital Leases | 90.58 | 8.86 | 6 |
| Cash | 0.15 | 0.14 | 0.16 |
| Total Equity | 261.53 | 263.71 | 259.19 |
| Long Term Investments | 0.01 | 0 | 0 |
| Retained Earnings(Accumulated Deficit) | 253.5 | 197.12 | 192.6 |
| Total Common Shares Outstanding | 0.8 | 0.8 | 0.8 |
| Property/Plant/Equipment Total-Gross | 8.42 | 381.1 | 337.58 |
| Tangible Book Valueper Share Common Eq | 325.45 | 328.1 | 322.37 |
| Total Liabilities | 190.08 | 151.59 | 121.32 |
| Total Debt | 108.46 | 66.77 | 51.82 |
| Short Term Investments | 0.06 | Not available | Not available |
| Cashand Short Term Investments | 0.21 | 0.14 | 0.16 |
| Total Receivables Net | 63.81 | 57.82 | 59.12 |
| Deferred Income Tax | 17.9 | 22.28 | 21.23 |
| Accounts Receivable-Trade Net | 62.41 | 40.64 | 47.34 |
| Property/Plant/Equipment Total-Net | 295.45 | 275.97 | 245.69 |
| Total Current Liabilities | 153.46 | 115.38 | 81.96 |
| Total Inventory | 73.01 | 70.47 | 64.86 |
| Accounts Payable | 53.95 | 57.4 | 43.52 |
| Other Currentliabilities Total | 8.26 | 1.22 | 0.91 |
| Total Long Term Debt | 17.88 | 13.32 | 17.47 |
| Intangibles Net | 0.09 | 0.15 | 0.22 |
| Other Long Term Assets Total | 4.74 | 2.04 | 1.94 |
| Total Current Assets | 151.31 | 134.41 | 130.22 |
| Accumulated Depreciation Total | Not available | -105.13 | -91.88 |
| Other Equity Total | Not available | 0.17 | 0.16 |
| Prepaid Expenses | Not available | 4.33 | 3.64 |
| Additional Paid-In Capital | Not available | 58.39 | 58.39 |
| Notes Payable/Short Term Debt | Not available | 44.59 | 28.35 |
| Note Receivable-Long Term | Not available | 2.74 | 2.42 |
Fundamentals
Valuation and ratios
Valuation
Price to Sale Ratio0.51
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskHigh risk
Board Risk64
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
Peer data unavailable in the company profile payload.
Shareholding
Ownership
- Promoter
- 62.70%
- FII
- 0.02%
- MF
- 0.06%
- Other
- 37.24%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Emkay Global and 10 Other Stocks Hit 20% Upper Circuit Today; Do You Own Any? - Trade BrainsMarket news · 3 Jun 2026, 3:37 pm
Emkay Global and 10 Other Stocks Hit 20% Upper Circuit Today; Do You Own Any? Trade Brains
Micro-Cap AksharChem Locks at Upper Circuit — Rs 1.59 Crore Turnover and Rising Delivery Tell the Story - Markets MojoMarket news · 3 Jun 2026, 1:31 pm
Micro-Cap AksharChem Locks at Upper Circuit — Rs 1.59 Crore Turnover and Rising Delivery Tell the Story Markets Mojo
Zydus receives warning letter from USFDA for its Baddi site - Business StandardMarket news · 3 Jun 2026, 12:32 pm
Zydus receives warning letter from USFDA for its Baddi site Business Standard
Gujarat Alkalies to source hybrid renewable energy from CLEANMAX - Business StandardMarket news · 3 Jun 2026, 12:32 pm
Gujarat Alkalies to source hybrid renewable energy from CLEANMAX Business Standard
India's services sector growth hits 6-month high in May - Business StandardMarket news · 3 Jun 2026, 12:31 pm
India's services sector growth hits 6-month high in May Business Standard
USTR proposes 12.5% additional duties on India and 53 other countries over forced labour import violations - Business StandardMarket news · 3 Jun 2026, 12:31 pm
USTR proposes 12.5% additional duties on India and 53 other countries over forced labour import violations Business Standard
Corporate actions
Events
- annual General MeetingPOM
- dividendRs.0.5000 per share(5%)Final Dividend
- board MeetingsAudited Results
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
- dividendRs.0.7500 per share(7.5%)Final Dividend
- board MeetingsTo consider other business matters.
Rusaka Markets Community
Discussion and sentiment for AksharChem India Ltd
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Not available
Company facts
- Industry
- Chemical Manufacturing
- Sector
- Chemical Manufacturing
- NSE Code
- AKSHARCHEM
- BSE Code
- 524598
Questions
Stock FAQ
What is the symbol and ISIN of AksharChem India Ltd?
AksharChem India Ltd has the symbol AKSHARCHEM and ISIN - INE542B01011.
What is the current price of AksharChem India Ltd?
AksharChem India Ltd is currently trading at INR 382.00.
What are the year high and year low of AksharChem India Ltd?
AksharChem India Ltd has a year high of INR 471.65 and a year low of INR 0.00.
What is the market capitalization of AksharChem India Ltd?
AksharChem India Ltd has a market capitalization of INR 190.39 crore.
What is the P/E ratio of AksharChem India Ltd?
AksharChem India Ltd has a P/E ratio of NA.
What is the dividend yield of AksharChem India Ltd?
AksharChem India Ltd has a dividend yield of NA.
How is the financial performance of AksharChem India Ltd based on revenue, net income, and EPS?
AksharChem India Ltd has revenue of INR 372.43 crore, net income of INR -0.44 crore, and EPS of NA.
What is the book value of AksharChem India Ltd?
AksharChem India Ltd has a book value of NA.
What is the debt-to-equity ratio of AksharChem India Ltd?
AksharChem India Ltd has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of AksharChem India Ltd?
AksharChem India Ltd has a price-to-book ratio of NA and a price-to-sales ratio of 0.51.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.